Purchase Order 36C26124P0236
Award Date
11/13/23
Potential Completion Date
2/12/24
Potential Value
$99K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Denver Solutions, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Denver Solutions, LLC has been awarded a firm fixed-price purchase order totaling $40,498.10 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The award is for ropivacaine hydrochloride injection to support medical centers in Palo Alto, California, with no set-aside designation applied. Denver Solutions will supply the pharmaceutical requested under the original solicitation as the prime contractor. Additionally, Denver Solutions holds...
This federal contract award, with an ID of 36C26121P1077, was issued by the Department of Veterans Affairs (VA) to Denver Solutions, LLC, a for-profit limited liability company based in Greenwood Village, Colorado. The contract is a firm fixed-price purchase order with a ceiling value of $95,470.00 and an ultimate completion date of September 30, 2021. The contract covers the delivery of various pharmaceutical products, including ropivacaine 0.2% 550mL, ephedrine 5mg/mL, ketamine 10mg/mL, and...
This is a federal delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 400 mg/200 mL ropivacaine 0.2% in 200 mL doses, with a ceiling value of $6,449.98 and a completion date of June 18, 2024. The contract is a firm fixed-price delivery order and is not designated as a set-aside. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,861.66 firm fixed-price delivery order is for the supply of 400 mg/200 mL ropivacaine 0.2% injectables. The contract has a period of performance through December 3, 2024 and was awarded on December 2, 2020. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to...
The Defense Logistics Agency awarded a $244,950 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ropivacaine hydrochloride injection USP, 0.5% 150 mg/30 mL single-dose vials. The contract calls for the delivery of 30 mL vials of the specified anesthetic to a facility in Conshohocken, Pennsylvania by June 30, 2023. As a major provider of medical supplies and pharmaceuticals to the U.S. military and other government agencies, this award supports the Defense Logistics...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 400mg/200mL ropivacaine hydrochloride 0.2% solution, a specialty pharmaceutical product used for anesthesia and pain relief. The contract has a ceiling value of $11,448.50 and a performance period ending on April 3, 2024. AmerisourceBergen Drug Corp holds an...
The Defense Logistics Agency awarded a $843.78 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 mg/100 ml vials of ropivacaine hydrochloride injection. As the prime contractor, Amerisourcebergen will deliver 100 ml vials of the anesthetic to its facility in Conshohocken, Pennsylvania within the period of performance from August 23 to August 24, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to support the agency's medical supply...
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for $599 worth of ropivacaine hydrochloride injection USP, 0.2% 200 mg/100 mL in 100 mL single-dose flexible containers. The place of performance is Park Ridge, Illinois and the completion date is April 21, 2022. No set-aside designation was used for this firm fixed price contract, which was awarded on April 20, 2022 to supply this generic anesthetic medication. As the Defense Logistics Agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,558.35, is for the supply of 400 mg/200 mL vials of Ropivacaine 0.2% anesthetic. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
The Defense Logistics Agency awarded a $6,486.90 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 mg/200 ml vials of ropivacaine hydrochloride, a long-acting amide local anesthetic. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 4-5, 2023. The order was placed under an existing DLA pharmaceuticals contract vehicle to supply anesthetics and other drug products in support of U.S....